Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Plex Pharmaceuticals logo — Driving pivotal academic breakthroughs into safe and effecti...

Plex Pharmaceuticals

Driving pivotal academic breakthroughs into safe and effective treatments for neglected neurodegenerative conditions.

Founded 2009 Grant Total: $2.87M Biotechnology, Medical Devices +1

General Information

Company Name Plex Pharmaceuticals
Founded Year 2009
Founders / Decision Makers
Team member
Industries Biotechnology, Medical Devices, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Plex Pharmaceuticals. To contact Plex Pharmaceuticals, visit plexpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Plex Pharmaceuticals compare?

A PDF of Plex Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Plex Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Plex Pharmaceuticals

Plex Pharmaceuticals is a biotechnology and pharmaceutical startup founded in 2009. The company's slogan, "Driving pivotal academic breakthroughs into safe and effective treatments for neglected neurodegenerative conditions," aligns with its mission to accelerate seminal academic discoveries into safe and effective treatments. With a primary focus on neurodegenerative disorders, Plex aims to address unmet and under-served medical needs. The company recently received a $1.60M grant investment on 08 July 2020 from the National Institutes of Health. This investment reflects external confidence in the potential of Plex Pharmaceuticals to make significant advancements in the treatment of neurodegenerative conditions.

Business keywords: neurodegenerative disorders, medical research, academic breakthroughs, treatments, neuroscience, drug development, biomedical research, pharmaceuticals

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.60M 1
National Institutes of Health
08 Jul 2020
Grant $600.00K 1
National Institute of Allergy and Infectious Diseases
04 Feb 2020
Seed Round $670.00K -
14 Jul 2016

Plex Pharmaceuticals Alternatives & Competitors

View All Alternatives
Plex Pharmaceuticals vs
Handl Therapeutics
Handl Therapeutics Belgium

Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through academic a...

Grant
Biotechnology, Health Care
Plex Pharmaceuticals vs
Prilenia
Prilenia United States

Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorde...

Series B
57 employees
Biotechnology, Health Care
Plex Pharmaceuticals vs
Cerevance
Cerevance United States

Cerevance a neuroscience company

Series C
35 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Plex Pharmaceuticals

Driving pivotal academic breakthroughs into safe and effective treatments for neglected neurodegenerative conditions.
Plex Pharmaceuticals was founded in 2009.
Plex Pharmaceuticals operates in Biotechnology, Medical Devices and Pharmaceutical. Its work centres on neurodegenerative disorders, medical research, academic breakthroughs and treatments.
Plex Pharmaceuticals has completed 3 funding rounds, raising a total of $2.87M. The latest funding stage is Grant.
Top alternatives and competitors to Plex Pharmaceuticals include Handl Therapeutics, Prilenia, Cerevance, Euthymics Bioscience, MacuCLEAR. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Plex Pharmaceuticals and Handl Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Plex Pharmaceuticals, https://bouncewatch.com/company/plex-pharmaceuticals, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes